Radiation dosimetry and first therapy results with a (124)I/(131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

INTRODUCTION: Since the prostate-specific membrane antigen (PSMA) is frequently over-expressed in prostate cancer (PCa) several PSMA-targeting molecules are under development to detect and treat metastatic castration resistant prostate cancer (mCRPC). We investigated the tissue kinetics of a small m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zechmann, Christian M., Afshar-Oromieh, Ali, Armor, Tom, Stubbs, James B., Mier, Walter, Hadaschik, Boris, Joyal, John, Kopka, Klaus, Debus, Jürgen, Babich, John W., Haberkorn, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052014/
https://www.ncbi.nlm.nih.gov/pubmed/24577951
http://dx.doi.org/10.1007/s00259-014-2713-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052014/
https://www.ncbi.nlm.nih.gov/pubmed/24577951
http://dx.doi.org/10.1007/s00259-014-2713-y

Ejemplares similares